SAFETY, EFFICACY AND TOLERABILITY OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS (ARNI) IN PATIENTS WITH CHRONIC HEART FAILURE. RMSR 2025, 3 (1), 522-531.